These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38067168)

  • 1. A New Era of Integration between Multiomics and Spatio-Temporal Analysis for the Translation of EMT towards Clinical Applications in Cancer.
    Fonseca Teixeira A; Wu S; Luwor R; Zhu HJ
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
    Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
    J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.
    Vasaikar SV; Deshmukh AP; den Hollander P; Addanki S; Kuburich NA; Kudaravalli S; Joseph R; Chang JT; Soundararajan R; Mani SA
    Br J Cancer; 2021 Jan; 124(1):259-269. PubMed ID: 33299129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.
    Jain AP; Sambath J; Sathe G; George IA; Pandey A; Thompson EW; Kumar P
    J Transl Med; 2022 Feb; 20(1):84. PubMed ID: 35148768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics technologies: role in disease biomarker discoveries and therapeutics.
    Dar MA; Arafah A; Bhat KA; Khan A; Khan MS; Ali A; Ahmad SM; Rashid SM; Rehman MU
    Brief Funct Genomics; 2023 Apr; 22(2):76-96. PubMed ID: 35809340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
    Yi H; Li G; Long Y; Liang W; Cui H; Zhang B; Tan Y; Li Y; Shen L; Deng D; Tang Y; Mao C; Tian S; Cai Y; Zhu Q; Hu Y; Chen W; Fang L
    Oncogene; 2020 Jul; 39(28):5152-5164. PubMed ID: 32535615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
    Zhang S; Fan W; He D
    J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).
    Ding XM
    Chin J Cancer; 2014 Mar; 33(3):140-7. PubMed ID: 24016392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer.
    Alvarez-Frutos L; Barriuso D; Duran M; Infante M; Kroemer G; Palacios-Ramirez R; Senovilla L
    Front Oncol; 2023; 13():1292046. PubMed ID: 38169859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.
    Zhang J; Hu Z; Horta CA; Yang J
    Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds.
    Ang HL; Mohan CD; Shanmugam MK; Leong HC; Makvandi P; Rangappa KS; Bishayee A; Kumar AP; Sethi G
    Med Res Rev; 2023 Jul; 43(4):1141-1200. PubMed ID: 36929669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression.
    Gröger CJ; Grubinger M; Waldhör T; Vierlinger K; Mikulits W
    PLoS One; 2012; 7(12):e51136. PubMed ID: 23251436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
    Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
    Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition.
    Koplev S; Lin K; Dohlman AB; Ma'ayan A
    PLoS Comput Biol; 2018 Jan; 14(1):e1005911. PubMed ID: 29293502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.